Suppr超能文献

痴呆症社区居住老年人的多种药物治疗和潜在不适当药物使用。

Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia.

机构信息

Buehler Center on Aging, Health & Society, Northwestern University, Chicago, IL, USA.

出版信息

Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):56-63. doi: 10.1097/WAD.0b013e31819d6ec9.

Abstract

This cross-sectional study examines the association between total prescription medication use and potentially inappropriate medication use (PIRx) among community-dwelling elderly patients with and without dementia. Data (September 2005 to September 2007) were from the National Institute on Aging-funded National Alzheimer's Coordinating Center Uniform Data Set. The study analyzed the Uniform Data Set initial visits of 4518 community-dwelling subjects aged 65 years and above with and without dementia (2665 and 1853, respectively). PIRx was defined using a partial list of the 2003 Beers criteria. Generalized linear mixed models were applied to estimate the association between PIRx and polypharmacy. In both groups (with and without dementia), subjects who received PIRx on average took more medications than those taking no PIRx. As the total number of medications used increased, the odds of having PIRx also increased, controlling for dementia diagnosis and other subject characteristics. Our key findings were consistent after considering 2 definitions of PIRx (with or without oral estrogens) and accounting for missing data. In summary, the total number of medications used is associated with PIRx among Alzheimer's Disease Centers community-dwelling elderly patients with and without dementia, with polypharmacy increasing the risk of PIRx. Ensuring appropriate medication use in this population is clinically important because of the significant risks for institutionalization.

摘要

这项横断面研究考察了社区居住的老年痴呆症和非痴呆症患者中总处方药物使用与潜在不适当药物使用(PIRx)之间的关联。数据(2005 年 9 月至 2007 年 9 月)来自美国国家老龄化研究所资助的国家阿尔茨海默病协调中心统一数据集。该研究分析了统一数据集 4518 名年龄在 65 岁及以上的社区居住的有和没有痴呆症的受试者(分别为 2665 名和 1853 名)的初始就诊情况。PIRx 使用 2003 年 Beers 标准的部分清单来定义。应用广义线性混合模型来估计 PIRx 与多种药物治疗之间的关联。在有和没有痴呆症的两组受试者中,平均接受 PIRx 的受试者服用的药物比未接受 PIRx 的受试者多。随着使用的药物总数增加,发生 PIRx 的几率也随之增加,控制了痴呆症诊断和其他受试者特征。在考虑了 2 种 PIRx 定义(包括或不包括口服雌激素)并考虑了缺失数据后,我们的主要发现仍然一致。总之,使用的药物总数与阿尔茨海默病中心社区居住的有和没有痴呆症的老年患者的 PIRx 相关,多种药物治疗增加了 PIRx 的风险。由于存在明显的住院风险,确保该人群中适当的药物使用具有重要的临床意义。

相似文献

1
Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia.
Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):56-63. doi: 10.1097/WAD.0b013e31819d6ec9.
2
Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia.
Am J Alzheimers Dis Other Demen. 2011 Dec;26(8):606-15. doi: 10.1177/1533317511432734. Epub 2011 Dec 28.
6
Potentially inappropriate medications in Chinese community-dwelling older adults.
Int J Clin Pharm. 2020 Apr;42(2):598-603. doi: 10.1007/s11096-020-00980-y. Epub 2020 Feb 5.
7
Racial and ethnic disparities in potentially inappropriate medication use in patients with dementia.
J Am Geriatr Soc. 2024 Nov;72(11):3360-3373. doi: 10.1111/jgs.19152. Epub 2024 Aug 21.
8
Medication misuse and overuse in community-dwelling persons with dementia.
J Am Geriatr Soc. 2023 Oct;71(10):3086-3098. doi: 10.1111/jgs.18463. Epub 2023 Jun 5.
10
Prevalence of potentially inappropriate prescription in community-dwelling patients with advanced dementia and palliative care needs.
Rev Esp Geriatr Gerontol. 2021 Jul-Aug;56(4):203-207. doi: 10.1016/j.regg.2021.03.001. Epub 2021 May 15.

引用本文的文献

3
Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data.
Front Pharmacol. 2024 Nov 5;15:1425442. doi: 10.3389/fphar.2024.1425442. eCollection 2024.
4
Prescribing patterns in people living with dementia in the community: A cross-sectional study.
Australas J Ageing. 2025 Mar;44(1):e13380. doi: 10.1111/ajag.13380. Epub 2024 Oct 27.
5
A need to integrate pharmacological management for multimorbidity into dementia guidelines in Australia.
Front Public Health. 2024 Jul 23;12:1425195. doi: 10.3389/fpubh.2024.1425195. eCollection 2024.
9
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia.
Front Aging Neurosci. 2023 Oct 23;15:1260427. doi: 10.3389/fnagi.2023.1260427. eCollection 2023.
10
Medication Reviews and Clinical Outcomes in Persons with Dementia: A Scoping Review.
Pharmacy (Basel). 2023 Oct 20;11(5):168. doi: 10.3390/pharmacy11050168.

本文引用的文献

1
Diagnosis and treatment of dementia: 2. Diagnosis.
CMAJ. 2008 Mar 25;178(7):825-36. doi: 10.1503/cmaj.070798.
2
Medication as a risk factor for falls: critical systematic review.
J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1172-81. doi: 10.1093/gerona/62.10.1172.
3
Healthcare outcomes associated with beers' criteria: a systematic review.
Ann Pharmacother. 2007 Mar;41(3):438-47. doi: 10.1345/aph.1H473. Epub 2007 Feb 20.
4
Polypharmacy and prescribing quality in older people.
J Am Geriatr Soc. 2006 Oct;54(10):1516-23. doi: 10.1111/j.1532-5415.2006.00889.x.
5
Dementia with lewy bodies: therapeutic opportunities and pitfalls.
Consult Pharm. 2006 Jul;21(7):563-75. doi: 10.4140/tcp.n.2006.563.
6
Pharmacological treatment of Alzheimer's Disease.
Aging Clin Exp Res. 2006 Apr;18(2):158-62. doi: 10.1007/BF03327433.
7
Polypharmacy and falls in the middle age and elderly population.
Br J Clin Pharmacol. 2006 Feb;61(2):218-23. doi: 10.1111/j.1365-2125.2005.02543.x.
8
Health outcomes and polypharmacy in elderly individuals: an integrated literature review.
J Gerontol Nurs. 2005 Sep;31(9):4-11. doi: 10.3928/0098-9134-20050901-04.
9
Potentially inappropriate medication use among elderly home care patients in Europe.
JAMA. 2005 Mar 16;293(11):1348-58. doi: 10.1001/jama.293.11.1348.
10
Potential pitfalls of disease-specific guidelines for patients with multiple conditions.
N Engl J Med. 2004 Dec 30;351(27):2870-4. doi: 10.1056/NEJMsb042458.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验